Overview and Scope
Renal denervation devices are minimally invasive medical devices used to treat hypertension (high blood pressure) that have not improved with other treatments. A catheter is passed into the renal arteries that ablate sympathetic nerves in the vessel wall using radiofrequency energy to allow greater blood flow to the kidneys.
Sizing and Forecast
The renal denervation devices market size has grown exponentially in recent years. It will grow from $0.42 billion in 2023 to $0.57 billion in 2024 at a compound annual growth rate (CAGR) of 35.1%. The growth in the historic period can be attributed to increased hypertension cases, clinical research and studies, increased in cardiovascular diseases, initial fda approval and regulatory developments, market entry of renal denervation systems.
The renal denervation devices market size is expected to see exponential growth in the next few years. It will grow to $1.73 billion in 2028 at a compound annual growth rate (CAGR) of 32.3%. The growth in the forecast period can be attributed to patient-centric approach, healthcare infrastructure development, growing awareness and acceptance, focus on minimally invasive therapies, market entry of new devices. Major trends in the forecast period include integration of artificial intelligence (ai) and machine learning, regulatory landscape changes, shift towards minimally invasive procedures, emphasis on clinical evidence, remote monitoring and telehealth integration.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/renal-denervation-devices-global-market-report
Segmentation & Regional Insights
The renal denervation devices market covered in this report is segmented –
1) By Product: Simplicity Renal Denervation System, EnligHTN, Vessix Renal Denervation System, Iberis Renal Sympathetic Denervation System, Paradise Renal Denervation System, Other Products
2) By Technology: Radio Frequency Ablation, Ultrasound Energy-Based RDN, Brachytherapy, Chemical Ablation, Other Technologies
3) By End-Users: Hospitals, Cardiovascular research centre, Other End-Users
Europe was the largest region in the renal denervation devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global renal denervation devices market report during the forecast period. The regions covered in the renal denervation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=10631&type=smp
Major Driver Impacting Market Growth
Increased prevalence of hypertension is expected to drive the growth of the renal denervation devices market growing forward. Hypertension, also known as high blood pressure, is a condition in which the force of blood flowing through the blood vessels is consistently too high. Renal denervation is a catheter-based procedure that has emerged as a potential therapeutic option for patients with resistant hypertension. Renal denervation is a minimally invasive, investigational procedure to treat hypertension that hasn’t responded to medication. For instance, in January 2023, according to a report published by the Mississippi State Department of Health, a US-based Mississippi state health agency, nearly 1 million adult Mississippians (43.9%) had high blood pressure as of the year 2021. In 2021, MS had a prevalence of hypertension that was 36.3% higher than the US average (MS: 43.9%, US: 32.2%). Therefore, the increased prevalence of hypertension will promote the growth of the renal denervation devices market.
Key Industry Players
Major companies operating in the renal denervation devices market report are Boston Scientific Corporation, CardioSonic Ltd., Kona Medical Inc., Medtronic PLC, Mercator MedSystems Inc., ReCor Medical, Abbott Laboratories, Ablative Solutions Inc., Terumo Corporation, Symple Surgical Inc., St. Jude Medical Inc., Johnson & Johnson Services Inc., Theragenics Corporation, Vascular Dynamics Inc., Otsuka Holdings Co. Ltd., Cardiovascular Systems Inc., Celonova Biosciences Inc., Concept Medical Inc., Cook Medical LLC, Cardinal Health Inc., Creganna Medical, Endologix Inc., Endospan Ltd., Enopace Biomedical Ltd., InspireMD Inc., MicroPort Scientific Corporation, Miracor Medical Systems GmbH, Nexeon MedSystems Inc., Asahi Kasei Corporation, Thermocool Limited
The renal denervation devices market report table of contents includes:
1. Executive Summary
2. Renal Denervation Devices Market Characteristics
3. Renal Denervation Devices Market Trends And Strategies
4. Renal Denervation Devices Market – Macro Economic Scenario
5. Global Renal Denervation Devices Market Size and Growth
.
.
.
31. Global Renal Denervation Devices Market Competitive Benchmarking
32. Global Renal Denervation Devices Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Renal Denervation Devices Market
34. Renal Denervation Devices Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
